COVID-19 testing and treatment


Assess your risk

You should get tested for COVID-19 if:

  • You are feeling sick and are experiencing symptoms of COVID-19, regardless or vaccination status or prior infection

  • You’ve had close contact to someone with suspected or confirmed COVID-19
    • Fully vaccinated people should be tested 3-5 days after exposure, and wear a mask in public indoor settings for 14 days or until they receive a negative test result
    • People who have tested positive for COVID-19 within the past 3 months and recovered do not need to get tested following an exposure as long as they do not develop new symptoms

  • You are unvaccinated and have taken part in activities that put yourself at higher risk for COVID-19 because you cannot physically distance as needed to avoid exposure, such as travel, attending large social or mass gatherings, or being in crowded or poorly-ventilated indoor settings
  • You have been asked or referred to get tested by your healthcare provider, or state, tribal, local, or territorial health department

Find a testing site near you

COVID-19 test availability changes daily. Call the testing site before you go to learn about testing criteria, availability, and hours.

  • Visit a Providence testing location
  • Visit your state, tribal, or local health department’s website to find a community testing event
  • Visit your healthcare provider or public health department clinic
  • Self-testing kits are available at local pharmacies if you and your healthcare provider think this is a good option for you

Testing coverage

Currently, medically appropriate COVID-19 tests have a $0 cost-share. Medically appropriate COVID-19 tests are those that are either FDA authorized or approved and ordered or reviewed by a health care professional to either 1) diagnose due to symptoms or potential exposure, or 2) help in the treatment of the virus for a person. This benefit coverage applies to both in-network and out-of-network tests for Medicare Advantage, Individual (marketplace and direct) and employer-sponsored health plans.

  • Providence generally does not cover COVID-19 testing for public health surveillance or employment purposes. State variations and regulations may apply.
  • Remember to visit network health care providers and always show your Providence member ID card for COVID-19 testing or related services.

Treatment for COVID-19 for members who are not in the hospital

Treatment is not a substitute for vaccination against COVID-19. Vaccines are the best protection from COVID-19.

COVID-19 treatment options such as monoclonal antibodies (mABs) have been issued emergency use authorization (EUA) by the FDA for members who are not hospitalized. Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses.

  • Members who are not hospitalized may qualify for monoclonal antibody treatment if you have COVID-19 with mild to moderate symptoms for 10 days or less and are at high risk for severe COVID-19.
  • Members who are not hospitalized may qualify for monoclonal antibody post-exposure prophylaxis therapy, therapy after one has been exposed to COVID-19, if they are a vulnerable person (not fully vaccinated or immunocompromised) and are at high risk for progression to severe COVID-19.

If you recently tested positive for COVID-19 or were recently exposed to COVID-19, talk to your healthcare provider to see if monoclonal antibody treatment is right for you.

All patients testing positive for COVID-19 within Providence will be considered and reviewed for monoclonal antibody treatment.

If you test positive for COVID-19 outside of Providence, talk to your healthcare provider about monoclonal antibody therapy.

Find monoclonal antibody therapy for COVID-19

Members should first talk to their healthcare provider about monoclonal antibody therapy.

Additionally, the U.S. Department of Health and Human Services (HHS) has a call center available to answer questions and provide information related to monoclonal antibody therapeutic treatments at the following phone numbers: 1-877-332-6585 (English language); 1-877-366-0310 (Spanish language).

  • HHS also has a national map that displays locations that have received shipments of monoclonal antibodies within the past several weeks. Members should talk to their healthcare provider before contacting a location to receive treatment.

Treatment coverage

As a Providence Health Plan member, all cost sharing for treatment of COVID-19 will be waived for service dates beginning April 1, 2020 through December 31, 2021. This applies to in-network inpatient, outpatient, facility and professional visits.

To view your benefits and plan details, log in to your myProvidence account

Have questions?

We're here to help you understand your comprehensive coverage and access genuine care. Call our customer service team at 800-878-4445 (TTY:711) Monday through Friday, 8 a.m. to 5 p.m. (Pacific Time).

Need help?

Hey!

You are now leaving the Providence Medicare Advantage Plans website. Are you sure thats what youd like to do?

No, I'll stay Yes, I'm leaving